在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Calcium-dependent phospholipase A2(PLA2G5) ELISA kit

  • 中文名稱:
    人鈣依賴性磷脂酶A2(PLA2G5)酶聯(lián)免疫試劑盒
  • 貨號:
    CSB-EL018103HU
  • 規(guī)格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    人鈣依賴性磷脂酶A2(PLA2G5)酶聯(lián)免疫試劑盒(CSB-EL018103HU)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的PLA2G5含量。PLA2G5是一種重要靶點。它屬于磷脂酶A2家族成員,在機體炎癥反應(yīng)、細胞膜代謝等過程中發(fā)揮作用。研究機制方面,主要聚焦其活性調(diào)節(jié)、與其他信號通路的相互作用,解析其在疾病發(fā)生發(fā)展中的角色以探索潛在治療策略。試劑盒檢測范圍為0.18 ng/mL-12 ng/mL,本產(chǎn)品適用于基礎(chǔ)科研領(lǐng)域,如探究PLA2G5在動脈粥樣硬化、肥胖相關(guān)脂代謝異?;蜓装Y性疾病模型中的表達變化,亦可用于評估藥物干預(yù)對磷脂酶活性調(diào)控的體外研究,為脂質(zhì)信號通路機制解析提供高效檢測工具。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說明書。
  • 別名:
    Ca2+ dependent phospholipase A2 ELISA Kit; Calcium dependent phospholipase A2 ELISA Kit; Calcium-dependent phospholipase A2 ELISA Kit; DKFZp686C2294 ELISA Kit; FRFB ELISA Kit; Group V phospholipase A2 ELISA Kit; GV PLA2 ELISA Kit; gVPLA2 ELISA Kit; hVPLA(2) ELISA Kit; MGC46205 ELISA Kit; OTTHUMP00000044655 ELISA Kit; PA2G5_HUMAN ELISA Kit; Phosphatidylcholine 2 acylhydrolase ELISA Kit; Phosphatidylcholine 2-acylhydrolase 5 ELISA Kit; Phospholipase A2 group V ELISA Kit; PLA2 10 ELISA Kit; PLA2 G5 ELISA Kit; PLA2-10 ELISA Kit; Pla2g5 ELISA Kit; sPLA2 Type V ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    0.18 ng/mL-12 ng/mL
  • 靈敏度:
    0.04 ng/mL
  • 反應(yīng)時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領(lǐng)域:
    Metabolism
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human PLA2G5 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    SampleSerum(n=4)
    1:5Average %89
    Range %84-93
    1:10Average %98
    Range %84-102
    1:20Average %104
    Range %100-110
    1:40Average %95
    Range %90-100
  • 回收率:
    The recovery of human PLA2G5 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 8480-88
    EDTA plasma (n=4)9691-100
  • 標(biāo)準(zhǔn)曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/mlOD1OD2AverageCorrected
    122.207 2.150 2.179 2.023
    61.768 1.801 1.785 1.629
    31.202 1.184 1.193 1.037
    1.50.683 0.634 0.659 0.503
    0.750.403 0.428 0.416 0.260
    0.3750.321 0.301 0.311 0.155
    0.180.245 0.227 0.236 0.080
    00.159 0.152 0.156
  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

產(chǎn)品評價

靶點詳情

  • 功能:
    Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids. Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity), preferentially releasing fatty acyl groups with a low degree of unsaturation such as oleoyl (C18:1) and linoleoyl (C18:2) groups. Hydrolyzes low-density lipoprotein (LDL) phospholipids releasing unsaturated fatty acids that drive macrophage polarization toward an M2 phenotype. May act in an autocrine and paracrine manner. Contributes to lipid remodeling of cellular membranes at different subcellular locations and generation of lipid mediators involved in pathogen clearance. Cleaves sn-2 fatty acyl chains of cardiolipin, a major component of the inner membrane of mitochondria and bacterial membranes. Promotes phagocytosis of bacteria in macrophages through production of lysophosphatidylethanolamines. Displays bactericidal activity against Gram-positive bacteria by directly hydrolyzing phospholipids of the bacterial membrane. Promotes phagocytosis and killing of ingested fungi likely through controlling phagosome-lysosome fusion and phagosome maturation. Plays a role in biosynthesis of cysteinyl leukotrienes (CysLTs) in myeloid cells. In eosinophils, triggers perinuclear arachidonate release and LTC4 synthesis in a PLA2G4A-independent way. In neutrophils, amplifies CysLTs biosynthesis initiated by PLA2G4A. Promotes immune complex clearance in macrophages via stimulating synthesis of CysLTs, which act through CYSLTR1 to trigger phagocytosis. May regulate antigen processing in antigen-presenting cells. In pulmonary macrophages regulates IL33 production required for activation of group 2 innate lymphoid cells. May play a role in the biosynthesis of N-acyl ethanolamines that regulate energy metabolism. Hydrolyzes N-acyl phosphatidylethanolamines to N-acyl lysophosphatidylethanolamines, which are further cleaved by a lysophospholipase D to release N-acyl ethanolamines.
  • 基因功能參考文獻:
    1. Low GV-PLA2 expression is associated with cancer. PMID: 26715269
    2. The clinical findings in this family suggest a diagnosis of benign familial fleck retina with excellent prognosis, in which the PLA2G5 gene may play a role. PMID: 25549071
    3. sPLA2-V plays a thrombogenic role by impairing the ability of EPCR to promote protein C activation. PMID: 25069533
    4. results demonstrate that EPCR is overexpressed and mediates the aggressive behavior of rheumatoid synovial fibroblasts, and is likely driven by group V secretory phospholipase A2 PMID: 24495480
    5. expression of PLA2s-IIE and -V correlates with the development of calcification as well as the expression of pro-osteogenic molecules in human aortic valves PMID: 25132377
    6. There is no association between rs525380 polymorphism of PLA2G5 and coronary heart disease. PMID: 24563418
    7. Our results demonstrate the association of the PLA2G5 rs11573191 polymorphism with premature CAD. In our study, it was possible to distinguish one haplotype associated with increased risk of premature CAD and hypertension. PMID: 24959594
    8. Human group V secretory phospholipase A2 is associated with lipid rafts and internalized in a flotillindependent pathway. PMID: 24042857
    9. Our studies identified a unique function of gV-sPLA2 in activation of macrophages PMID: 23650617
    10. The effects of acidic pH on the activity of recombinant human group V secreted phospholipase A(2) (sPLA(2)-V) toward small VLDL (sVLDL), IDL, and LDL, on the binding of these apoB-100-containing lipoproteins to human aortic proteoglycans, were examined. PMID: 22041135
    11. Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina PMID: 22137173
    12. Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro PMID: 20448053
    13. circulating human neutrophils express groups V and X sPLA(2) (GV and GX sPLA(2)) mRNA and contain GV and GX sPLA(2) proteins, whereas GIB, GIIA, GIID, GIIE, GIIF, GIII, and GXII sPLA(2)s are undetectable PMID: 11741884
    14. group V phospholipase A2 induces group IVA phospholipase A2-independent cysteinyl leukotriene synthesis in human eosinophils PMID: 12796497
    15. sPLA2-V expression in hepatocytes is induced by viral infection, fibrosis, and circulatory disturbance. Immunostaining using sPLA2-V antibody is useful for the detection of injured hepatocytes in patients with liver diseases. PMID: 15377291
    16. foam cell formation is promoted by a SR-A- and CD36-independent process that involves cellular proteoglycans and Group V secretory phospholipase A2-modified low density lipoprotein PMID: 16040605
    17. Group V sPLA2 was expressed in ischaemic cardiomyocytes around the lesion, while no expression was observed in normal heart. PMID: 16115226
    18. present results raise the possibility that group V and X sPLA2s may play a role in innate immunity against adenoviral infection in the respiratory tract PMID: 16146426
    19. group V PLA2 released from neighboring cells may function in triggering the activation of inflammatory cells under physiological conditions PMID: 16476735
    20. Group V phospholipase A2, endogenously secreted from activated epithelial cells, promotes secretion of leukotriene C4 from cocultured eosinophils. PMID: 16785555
    21. PLA2G5 tSNP haplotypes demonstrate an association with total and LDL cholesterol and oxLDL/LDL. PMID: 17545304

    顯示更多

    收起更多

  • 相關(guān)疾病:
    Fleck retina, familial benign (FRFB)
  • 亞細胞定位:
    Secreted. Cell membrane. Cytoplasmic vesicle, phagosome. Recycling endosome. Golgi apparatus, cis-Golgi network. Golgi apparatus, trans-Golgi network.
  • 蛋白家族:
    Phospholipase A2 family
  • 組織特異性:
    Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). Expressed in monocytes and macrophages.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 9038

    OMIM: 228980

    KEGG: hsa:5322

    STRING: 9606.ENSP00000364249

    UniGene: Hs.319438



主站蜘蛛池模板: 精品亚洲麻豆1区2区3区| 亚洲 欧美 影音先锋| 国内精品久久久久久久影视| 伊人精品一本久久综合| 国产美女裸身网站免费观看视频| 国产 中文 制服丝袜 另类| 国产成人愉拍精品| 久久午夜无码鲁丝片午夜精品| 韩国三级中文字幕hd久久精品| 强被迫伦姧惨叫人妻系列| 久久www成人片免费看| 久久无码高潮喷水| 亚洲色婷婷久久精品av蜜桃久久| 国产性夜夜春夜夜爽1a片| 国产voyeur精品偷窥222| 亚洲欧美v国产蜜芽tv| 国产精品亚洲a∨天堂| 秋霞av鲁丝片一区二区| 国产97在线 | 亚洲| 久久亚洲精品无码网站| 欧美 日产 国产在线观看| 一本色道久久综合狠狠躁篇| 欧美搡bbbbb搡bbbbb| 无码人妻久久久一区二区三区| 无码人妻一区二区三区免费视频| 欲香欲色天天综合久久| 男女啪啪激烈高潮喷出gif免费| 亚洲永久无码7777kkk| 中文字幕亚洲日韩无线码| 色欲天天婬色婬香综合网完整 | 日韩卡1卡2 卡三卡免费| 真实国产乱子伦对白在线播放| 国产在线精品一区二区三区不卡| 人人妻人人做人人爽| 中文国产乱码在线人妻一区二区| 成人免费无码视频在线网站 | 亚洲人成网站在线播放2019| 久久69精品久久久久久hb| 性饥渴的农村熟妇| 欧美v亚洲v日韩v最新在线| 无码中文人妻在线一区|